Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Neogenomics Inc Issues Q2 2013 Guidance; Revenue Guidance Below Analysts' Estimates


Thursday, 25 Apr 2013 07:03am EDT 

Neogenomics Inc announced that for the second quarter of 2013, it expects revenue of $15.8 - $16.4 million and net income of $0.00 to $0.01 per share. This guidance is based on organic growth in the current business, and the Company reserves the right to adjust this guidance at any time based on the ongoing execution of its business plan. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $16.9 million and EPS of $0.01 for second quarter of 2013. 

Company Quote

4.16
-0.02 -0.48%
19 Dec 2014